• Citer

Oxaliplatin/5fluorouracil-based chemotherapy was active and well tolerated in heavily pretreated patients with ovarian carcinoma.

par Rosa, Daniela Dornelles;Awada, Ahmad ;Mano, Max S.;Selleslags, Jean;Lebrun, Fabienne;Gil, Thierry ;Piccart-Gebhart, Martine ;D'Hondt, Veronique
Référence Archives of gynecology and obstetrics, 278, 5, page (457-462)
Publication Publié, 2008-11

Article révisé par les pairs

• Détails
• Contenu

Titre:	Oxaliplatin/5fluorouracil-based chemotherapy was active and well tolerated in heavily pretreated patients with ovarian carcinoma.
Auteur:	Rosa, Daniela Dornelles; Awada, Ahmad; Mano, Max S.; Selleslags, Jean; Lebrun, Fabienne; Gil, Thierry; Piccart-Gebhart, Martine; D'Hondt, Veronique
Informations sur la publication:	Archives of gynecology and obstetrics, 278, 5, page (457-462)
Statut de publication:	Publié, 2008-11
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Chemotherapy
	Epithelial ovarian carcinoma
	FOLFOX
	Oxaliplatin
MeSH keywords:	Aged
	Antineoplastic Agents -- administration & dosage
	Antineoplastic Agents -- adverse effects
	Antineoplastic Combined Chemotherapy Protocols -- adverse effects
	Carcinoma -- drug therapy
	Carcinoma -- pathology
	Cohort Studies
	Disease-Free Survival
	Fallopian Tube Neoplasms -- drug therapy
	Fallopian Tube Neoplasms -- pathology
	Female
	Fluorouracil -- adverse effects
	Humans
	Leucovorin -- adverse effects
	Middle Aged
	Neoplasm Staging
	Organoplatinum Compounds -- administration & dosage
	Organoplatinum Compounds -- adverse effects
	Ovarian Neoplasms -- drug therapy
	Ovarian Neoplasms -- pathology
	Treatment Outcome
Note générale:	Clinical Trial
	Journal Article
Langue:	Anglais
Identificateurs:	urn:issn:0932-0067
	info:doi/10.1007/s00404-008-0592-9
	info:scp/51449084510
	info:pmid/18273626